A Bill That Could Federally Legalize Marijuana Reintroduced in the House

A Bill That Could Federally Legalize Marijuana Reintroduced in the House

A bill to remove marijuana from the federal list of controlled substances was reintroduced in the house. 

On May 28, US House Judiciary Chair Jerry Nadler reintroduced the MORE Act, also known as the Marijuana Opportunity Reinvestment and Expungement Act. 

According to the reports, if passed by both houses and signed by the president, the Act would federally legalize marijuana. This bill will also help the communities of color affected by drug wars. Several reports suggest that many young men, belonging to these communities, are often held under custody for nonviolent cannabis offenses. Some even had to serve time in prison. 

The MORE Act, if passed, would expunge criminal records of such men who were caught up in drug violence and had to serve time. 

Reportedly, a 5% tax would also be levied on marijuana consumption. 

Though this Act could effectively legalize recreational marijuana and bring social justice to the marginalized racial communities, this is not the first time it was introduced in the house. 

Last year, a similar bill was introduced in the house but it failed to pass in the republican controlled senate. Currently, 18 states and Washington DC have officially legalized adult-use marijuana. While the passing of the MORE Act would require at least 60 votes, which is highly unlikely, the widespread support for federal legalization across the US might keep the Act alive. 

Reportedly, the MORE Act could spark market growth by providing economic opportunities for plant-touching and ancillary businesses. This might also encourage interstate trade and the formation of regional cannabis centers. 

The bill also includes an opportunity trust fund which would fund local job training, legal aid, literacy and youth mentoring of the minors affected by drug wars and violence. This Act has been characterized as social-justice focused as it calls for reinvestment in communities affected by drugs and a need for a diverse marketplace.